<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE LCTL_TEXT SYSTEM "ltf.v1.5.dtd">
<LCTL_TEXT lang="spa">
<DOC id="L0C04CVOF" lang="spa" tokenization="tokenization_parameters.v5.0" grammar="none" raw_text_char_length="1154" raw_text_md5="99d9ab3692bbe2b9bf7e353f28f8400e">
<TEXT>
<SEG id="segment-0" start_char="1" end_char="71">
<ORIGINAL_TEXT>Baricitinib May Shorten Recovery Time in Hospitalized COVID-19 Patients</ORIGINAL_TEXT>
<TOKEN id="token-0-0" pos="word" morph="none" start_char="1" end_char="11">Baricitinib</TOKEN>
<TOKEN id="token-0-1" pos="word" morph="none" start_char="13" end_char="15">May</TOKEN>
<TOKEN id="token-0-2" pos="word" morph="none" start_char="17" end_char="23">Shorten</TOKEN>
<TOKEN id="token-0-3" pos="word" morph="none" start_char="25" end_char="32">Recovery</TOKEN>
<TOKEN id="token-0-4" pos="word" morph="none" start_char="34" end_char="37">Time</TOKEN>
<TOKEN id="token-0-5" pos="word" morph="none" start_char="39" end_char="40">in</TOKEN>
<TOKEN id="token-0-6" pos="word" morph="none" start_char="42" end_char="53">Hospitalized</TOKEN>
<TOKEN id="token-0-7" pos="unknown" morph="none" start_char="55" end_char="62">COVID-19</TOKEN>
<TOKEN id="token-0-8" pos="word" morph="none" start_char="64" end_char="71">Patients</TOKEN>
</SEG>
<SEG id="segment-1" start_char="76" end_char="88">
<ORIGINAL_TEXT>MONDAY, Sept.</ORIGINAL_TEXT>
<TOKEN id="token-1-0" pos="word" morph="none" start_char="76" end_char="81">MONDAY</TOKEN>
<TOKEN id="token-1-1" pos="punct" morph="none" start_char="82" end_char="82">,</TOKEN>
<TOKEN id="token-1-2" pos="word" morph="none" start_char="84" end_char="87">Sept</TOKEN>
<TOKEN id="token-1-3" pos="punct" morph="none" start_char="88" end_char="88">.</TOKEN>
</SEG>
<SEG id="segment-2" start_char="90" end_char="284">
<ORIGINAL_TEXT>14, 2020 (HealthDay News) -- Using an anti-inflammatory medicine along with the antiviral drug remdesivir appears to shorten COVID-19 patients' recovery time, according to drug company Eli Lilly.</ORIGINAL_TEXT>
<TOKEN id="token-2-0" pos="word" morph="none" start_char="90" end_char="91">14</TOKEN>
<TOKEN id="token-2-1" pos="punct" morph="none" start_char="92" end_char="92">,</TOKEN>
<TOKEN id="token-2-2" pos="word" morph="none" start_char="94" end_char="97">2020</TOKEN>
<TOKEN id="token-2-3" pos="punct" morph="none" start_char="99" end_char="99">(</TOKEN>
<TOKEN id="token-2-4" pos="word" morph="none" start_char="100" end_char="108">HealthDay</TOKEN>
<TOKEN id="token-2-5" pos="word" morph="none" start_char="110" end_char="113">News</TOKEN>
<TOKEN id="token-2-6" pos="punct" morph="none" start_char="114" end_char="114">)</TOKEN>
<TOKEN id="token-2-7" pos="punct" morph="none" start_char="116" end_char="117">--</TOKEN>
<TOKEN id="token-2-8" pos="word" morph="none" start_char="119" end_char="123">Using</TOKEN>
<TOKEN id="token-2-9" pos="word" morph="none" start_char="125" end_char="126">an</TOKEN>
<TOKEN id="token-2-10" pos="unknown" morph="none" start_char="128" end_char="144">anti-inflammatory</TOKEN>
<TOKEN id="token-2-11" pos="word" morph="none" start_char="146" end_char="153">medicine</TOKEN>
<TOKEN id="token-2-12" pos="word" morph="none" start_char="155" end_char="159">along</TOKEN>
<TOKEN id="token-2-13" pos="word" morph="none" start_char="161" end_char="164">with</TOKEN>
<TOKEN id="token-2-14" pos="word" morph="none" start_char="166" end_char="168">the</TOKEN>
<TOKEN id="token-2-15" pos="word" morph="none" start_char="170" end_char="178">antiviral</TOKEN>
<TOKEN id="token-2-16" pos="word" morph="none" start_char="180" end_char="183">drug</TOKEN>
<TOKEN id="token-2-17" pos="word" morph="none" start_char="185" end_char="194">remdesivir</TOKEN>
<TOKEN id="token-2-18" pos="word" morph="none" start_char="196" end_char="202">appears</TOKEN>
<TOKEN id="token-2-19" pos="word" morph="none" start_char="204" end_char="205">to</TOKEN>
<TOKEN id="token-2-20" pos="word" morph="none" start_char="207" end_char="213">shorten</TOKEN>
<TOKEN id="token-2-21" pos="unknown" morph="none" start_char="215" end_char="222">COVID-19</TOKEN>
<TOKEN id="token-2-22" pos="word" morph="none" start_char="224" end_char="231">patients</TOKEN>
<TOKEN id="token-2-23" pos="punct" morph="none" start_char="232" end_char="232">'</TOKEN>
<TOKEN id="token-2-24" pos="word" morph="none" start_char="234" end_char="241">recovery</TOKEN>
<TOKEN id="token-2-25" pos="word" morph="none" start_char="243" end_char="246">time</TOKEN>
<TOKEN id="token-2-26" pos="punct" morph="none" start_char="247" end_char="247">,</TOKEN>
<TOKEN id="token-2-27" pos="word" morph="none" start_char="249" end_char="257">according</TOKEN>
<TOKEN id="token-2-28" pos="word" morph="none" start_char="259" end_char="260">to</TOKEN>
<TOKEN id="token-2-29" pos="word" morph="none" start_char="262" end_char="265">drug</TOKEN>
<TOKEN id="token-2-30" pos="word" morph="none" start_char="267" end_char="273">company</TOKEN>
<TOKEN id="token-2-31" pos="word" morph="none" start_char="275" end_char="277">Eli</TOKEN>
<TOKEN id="token-2-32" pos="word" morph="none" start_char="279" end_char="283">Lilly</TOKEN>
<TOKEN id="token-2-33" pos="punct" morph="none" start_char="284" end_char="284">.</TOKEN>
</SEG>
<SEG id="segment-3" start_char="287" end_char="401">
<ORIGINAL_TEXT>Remdesivir -- from Gilead Sciences -- has previously been shown to reduce recovery time to an average of four days.</ORIGINAL_TEXT>
<TOKEN id="token-3-0" pos="word" morph="none" start_char="287" end_char="296">Remdesivir</TOKEN>
<TOKEN id="token-3-1" pos="punct" morph="none" start_char="298" end_char="299">--</TOKEN>
<TOKEN id="token-3-2" pos="word" morph="none" start_char="301" end_char="304">from</TOKEN>
<TOKEN id="token-3-3" pos="word" morph="none" start_char="306" end_char="311">Gilead</TOKEN>
<TOKEN id="token-3-4" pos="word" morph="none" start_char="313" end_char="320">Sciences</TOKEN>
<TOKEN id="token-3-5" pos="punct" morph="none" start_char="322" end_char="323">--</TOKEN>
<TOKEN id="token-3-6" pos="word" morph="none" start_char="325" end_char="327">has</TOKEN>
<TOKEN id="token-3-7" pos="word" morph="none" start_char="329" end_char="338">previously</TOKEN>
<TOKEN id="token-3-8" pos="word" morph="none" start_char="340" end_char="343">been</TOKEN>
<TOKEN id="token-3-9" pos="word" morph="none" start_char="345" end_char="349">shown</TOKEN>
<TOKEN id="token-3-10" pos="word" morph="none" start_char="351" end_char="352">to</TOKEN>
<TOKEN id="token-3-11" pos="word" morph="none" start_char="354" end_char="359">reduce</TOKEN>
<TOKEN id="token-3-12" pos="word" morph="none" start_char="361" end_char="368">recovery</TOKEN>
<TOKEN id="token-3-13" pos="word" morph="none" start_char="370" end_char="373">time</TOKEN>
<TOKEN id="token-3-14" pos="word" morph="none" start_char="375" end_char="376">to</TOKEN>
<TOKEN id="token-3-15" pos="word" morph="none" start_char="378" end_char="379">an</TOKEN>
<TOKEN id="token-3-16" pos="word" morph="none" start_char="381" end_char="387">average</TOKEN>
<TOKEN id="token-3-17" pos="word" morph="none" start_char="389" end_char="390">of</TOKEN>
<TOKEN id="token-3-18" pos="word" morph="none" start_char="392" end_char="395">four</TOKEN>
<TOKEN id="token-3-19" pos="word" morph="none" start_char="397" end_char="400">days</TOKEN>
<TOKEN id="token-3-20" pos="punct" morph="none" start_char="401" end_char="401">.</TOKEN>
</SEG>
<SEG id="segment-4" start_char="403" end_char="613">
<ORIGINAL_TEXT>Patients who also received Lilly's anti-inflammatory drug baricitinib (sold as Olumiant to treat rheumatoid arthritis) recovered one day sooner than those who took remdesivir alone, according to the company, the</ORIGINAL_TEXT>
<TOKEN id="token-4-0" pos="word" morph="none" start_char="403" end_char="410">Patients</TOKEN>
<TOKEN id="token-4-1" pos="word" morph="none" start_char="412" end_char="414">who</TOKEN>
<TOKEN id="token-4-2" pos="word" morph="none" start_char="416" end_char="419">also</TOKEN>
<TOKEN id="token-4-3" pos="word" morph="none" start_char="421" end_char="428">received</TOKEN>
<TOKEN id="token-4-4" pos="word" morph="none" start_char="430" end_char="436">Lilly's</TOKEN>
<TOKEN id="token-4-5" pos="unknown" morph="none" start_char="438" end_char="454">anti-inflammatory</TOKEN>
<TOKEN id="token-4-6" pos="word" morph="none" start_char="456" end_char="459">drug</TOKEN>
<TOKEN id="token-4-7" pos="word" morph="none" start_char="461" end_char="471">baricitinib</TOKEN>
<TOKEN id="token-4-8" pos="punct" morph="none" start_char="473" end_char="473">(</TOKEN>
<TOKEN id="token-4-9" pos="word" morph="none" start_char="474" end_char="477">sold</TOKEN>
<TOKEN id="token-4-10" pos="word" morph="none" start_char="479" end_char="480">as</TOKEN>
<TOKEN id="token-4-11" pos="word" morph="none" start_char="482" end_char="489">Olumiant</TOKEN>
<TOKEN id="token-4-12" pos="word" morph="none" start_char="491" end_char="492">to</TOKEN>
<TOKEN id="token-4-13" pos="word" morph="none" start_char="494" end_char="498">treat</TOKEN>
<TOKEN id="token-4-14" pos="word" morph="none" start_char="500" end_char="509">rheumatoid</TOKEN>
<TOKEN id="token-4-15" pos="word" morph="none" start_char="511" end_char="519">arthritis</TOKEN>
<TOKEN id="token-4-16" pos="punct" morph="none" start_char="520" end_char="520">)</TOKEN>
<TOKEN id="token-4-17" pos="word" morph="none" start_char="522" end_char="530">recovered</TOKEN>
<TOKEN id="token-4-18" pos="word" morph="none" start_char="532" end_char="534">one</TOKEN>
<TOKEN id="token-4-19" pos="word" morph="none" start_char="536" end_char="538">day</TOKEN>
<TOKEN id="token-4-20" pos="word" morph="none" start_char="540" end_char="545">sooner</TOKEN>
<TOKEN id="token-4-21" pos="word" morph="none" start_char="547" end_char="550">than</TOKEN>
<TOKEN id="token-4-22" pos="word" morph="none" start_char="552" end_char="556">those</TOKEN>
<TOKEN id="token-4-23" pos="word" morph="none" start_char="558" end_char="560">who</TOKEN>
<TOKEN id="token-4-24" pos="word" morph="none" start_char="562" end_char="565">took</TOKEN>
<TOKEN id="token-4-25" pos="word" morph="none" start_char="567" end_char="576">remdesivir</TOKEN>
<TOKEN id="token-4-26" pos="word" morph="none" start_char="578" end_char="582">alone</TOKEN>
<TOKEN id="token-4-27" pos="punct" morph="none" start_char="583" end_char="583">,</TOKEN>
<TOKEN id="token-4-28" pos="word" morph="none" start_char="585" end_char="593">according</TOKEN>
<TOKEN id="token-4-29" pos="word" morph="none" start_char="595" end_char="596">to</TOKEN>
<TOKEN id="token-4-30" pos="word" morph="none" start_char="598" end_char="600">the</TOKEN>
<TOKEN id="token-4-31" pos="word" morph="none" start_char="602" end_char="608">company</TOKEN>
<TOKEN id="token-4-32" pos="punct" morph="none" start_char="609" end_char="609">,</TOKEN>
<TOKEN id="token-4-33" pos="word" morph="none" start_char="611" end_char="613">the</TOKEN>
</SEG>
<SEG id="segment-5" start_char="616" end_char="631">
<ORIGINAL_TEXT>Associated Press</ORIGINAL_TEXT>
<TOKEN id="token-5-0" pos="word" morph="none" start_char="616" end_char="625">Associated</TOKEN>
<TOKEN id="token-5-1" pos="word" morph="none" start_char="627" end_char="631">Press</TOKEN>
</SEG>
<SEG id="segment-6" start_char="634" end_char="642">
<ORIGINAL_TEXT>reported.</ORIGINAL_TEXT>
<TOKEN id="token-6-0" pos="word" morph="none" start_char="634" end_char="641">reported</TOKEN>
<TOKEN id="token-6-1" pos="punct" morph="none" start_char="642" end_char="642">.</TOKEN>
</SEG>
<SEG id="segment-7" start_char="644" end_char="706">
<ORIGINAL_TEXT>Recovery is defined as being well enough to leave the hospital.</ORIGINAL_TEXT>
<TOKEN id="token-7-0" pos="word" morph="none" start_char="644" end_char="651">Recovery</TOKEN>
<TOKEN id="token-7-1" pos="word" morph="none" start_char="653" end_char="654">is</TOKEN>
<TOKEN id="token-7-2" pos="word" morph="none" start_char="656" end_char="662">defined</TOKEN>
<TOKEN id="token-7-3" pos="word" morph="none" start_char="664" end_char="665">as</TOKEN>
<TOKEN id="token-7-4" pos="word" morph="none" start_char="667" end_char="671">being</TOKEN>
<TOKEN id="token-7-5" pos="word" morph="none" start_char="673" end_char="676">well</TOKEN>
<TOKEN id="token-7-6" pos="word" morph="none" start_char="678" end_char="683">enough</TOKEN>
<TOKEN id="token-7-7" pos="word" morph="none" start_char="685" end_char="686">to</TOKEN>
<TOKEN id="token-7-8" pos="word" morph="none" start_char="688" end_char="692">leave</TOKEN>
<TOKEN id="token-7-9" pos="word" morph="none" start_char="694" end_char="696">the</TOKEN>
<TOKEN id="token-7-10" pos="word" morph="none" start_char="698" end_char="705">hospital</TOKEN>
<TOKEN id="token-7-11" pos="punct" morph="none" start_char="706" end_char="706">.</TOKEN>
</SEG>
<SEG id="segment-8" start_char="709" end_char="848">
<ORIGINAL_TEXT>The findings from the 1,000-person study, sponsored by the U.S. National Institute of Allergy and Infectious Diseases, were released Monday.</ORIGINAL_TEXT>
<TOKEN id="token-8-0" pos="word" morph="none" start_char="709" end_char="711">The</TOKEN>
<TOKEN id="token-8-1" pos="word" morph="none" start_char="713" end_char="720">findings</TOKEN>
<TOKEN id="token-8-2" pos="word" morph="none" start_char="722" end_char="725">from</TOKEN>
<TOKEN id="token-8-3" pos="word" morph="none" start_char="727" end_char="729">the</TOKEN>
<TOKEN id="token-8-4" pos="unknown" morph="none" start_char="731" end_char="742">1,000-person</TOKEN>
<TOKEN id="token-8-5" pos="word" morph="none" start_char="744" end_char="748">study</TOKEN>
<TOKEN id="token-8-6" pos="punct" morph="none" start_char="749" end_char="749">,</TOKEN>
<TOKEN id="token-8-7" pos="word" morph="none" start_char="751" end_char="759">sponsored</TOKEN>
<TOKEN id="token-8-8" pos="word" morph="none" start_char="761" end_char="762">by</TOKEN>
<TOKEN id="token-8-9" pos="word" morph="none" start_char="764" end_char="766">the</TOKEN>
<TOKEN id="token-8-10" pos="unknown" morph="none" start_char="768" end_char="770">U.S</TOKEN>
<TOKEN id="token-8-11" pos="punct" morph="none" start_char="771" end_char="771">.</TOKEN>
<TOKEN id="token-8-12" pos="word" morph="none" start_char="773" end_char="780">National</TOKEN>
<TOKEN id="token-8-13" pos="word" morph="none" start_char="782" end_char="790">Institute</TOKEN>
<TOKEN id="token-8-14" pos="word" morph="none" start_char="792" end_char="793">of</TOKEN>
<TOKEN id="token-8-15" pos="word" morph="none" start_char="795" end_char="801">Allergy</TOKEN>
<TOKEN id="token-8-16" pos="word" morph="none" start_char="803" end_char="805">and</TOKEN>
<TOKEN id="token-8-17" pos="word" morph="none" start_char="807" end_char="816">Infectious</TOKEN>
<TOKEN id="token-8-18" pos="word" morph="none" start_char="818" end_char="825">Diseases</TOKEN>
<TOKEN id="token-8-19" pos="punct" morph="none" start_char="826" end_char="826">,</TOKEN>
<TOKEN id="token-8-20" pos="word" morph="none" start_char="828" end_char="831">were</TOKEN>
<TOKEN id="token-8-21" pos="word" morph="none" start_char="833" end_char="840">released</TOKEN>
<TOKEN id="token-8-22" pos="word" morph="none" start_char="842" end_char="847">Monday</TOKEN>
<TOKEN id="token-8-23" pos="punct" morph="none" start_char="848" end_char="848">.</TOKEN>
</SEG>
<SEG id="segment-9" start_char="850" end_char="1005">
<ORIGINAL_TEXT>The study has not been published or reviewed by independent scientists, but U.S. health officials said Lilly's statement about the results was accurate, the</ORIGINAL_TEXT>
<TOKEN id="token-9-0" pos="word" morph="none" start_char="850" end_char="852">The</TOKEN>
<TOKEN id="token-9-1" pos="word" morph="none" start_char="854" end_char="858">study</TOKEN>
<TOKEN id="token-9-2" pos="word" morph="none" start_char="860" end_char="862">has</TOKEN>
<TOKEN id="token-9-3" pos="word" morph="none" start_char="864" end_char="866">not</TOKEN>
<TOKEN id="token-9-4" pos="word" morph="none" start_char="868" end_char="871">been</TOKEN>
<TOKEN id="token-9-5" pos="word" morph="none" start_char="873" end_char="881">published</TOKEN>
<TOKEN id="token-9-6" pos="word" morph="none" start_char="883" end_char="884">or</TOKEN>
<TOKEN id="token-9-7" pos="word" morph="none" start_char="886" end_char="893">reviewed</TOKEN>
<TOKEN id="token-9-8" pos="word" morph="none" start_char="895" end_char="896">by</TOKEN>
<TOKEN id="token-9-9" pos="word" morph="none" start_char="898" end_char="908">independent</TOKEN>
<TOKEN id="token-9-10" pos="word" morph="none" start_char="910" end_char="919">scientists</TOKEN>
<TOKEN id="token-9-11" pos="punct" morph="none" start_char="920" end_char="920">,</TOKEN>
<TOKEN id="token-9-12" pos="word" morph="none" start_char="922" end_char="924">but</TOKEN>
<TOKEN id="token-9-13" pos="unknown" morph="none" start_char="926" end_char="928">U.S</TOKEN>
<TOKEN id="token-9-14" pos="punct" morph="none" start_char="929" end_char="929">.</TOKEN>
<TOKEN id="token-9-15" pos="word" morph="none" start_char="931" end_char="936">health</TOKEN>
<TOKEN id="token-9-16" pos="word" morph="none" start_char="938" end_char="946">officials</TOKEN>
<TOKEN id="token-9-17" pos="word" morph="none" start_char="948" end_char="951">said</TOKEN>
<TOKEN id="token-9-18" pos="word" morph="none" start_char="953" end_char="959">Lilly's</TOKEN>
<TOKEN id="token-9-19" pos="word" morph="none" start_char="961" end_char="969">statement</TOKEN>
<TOKEN id="token-9-20" pos="word" morph="none" start_char="971" end_char="975">about</TOKEN>
<TOKEN id="token-9-21" pos="word" morph="none" start_char="977" end_char="979">the</TOKEN>
<TOKEN id="token-9-22" pos="word" morph="none" start_char="981" end_char="987">results</TOKEN>
<TOKEN id="token-9-23" pos="word" morph="none" start_char="989" end_char="991">was</TOKEN>
<TOKEN id="token-9-24" pos="word" morph="none" start_char="993" end_char="1000">accurate</TOKEN>
<TOKEN id="token-9-25" pos="punct" morph="none" start_char="1001" end_char="1001">,</TOKEN>
<TOKEN id="token-9-26" pos="word" morph="none" start_char="1003" end_char="1005">the</TOKEN>
</SEG>
<SEG id="segment-10" start_char="1008" end_char="1009">
<ORIGINAL_TEXT>AP</ORIGINAL_TEXT>
<TOKEN id="token-10-0" pos="word" morph="none" start_char="1008" end_char="1009">AP</TOKEN>
</SEG>
<SEG id="segment-11" start_char="1012" end_char="1020">
<ORIGINAL_TEXT>reported.</ORIGINAL_TEXT>
<TOKEN id="token-11-0" pos="word" morph="none" start_char="1012" end_char="1019">reported</TOKEN>
<TOKEN id="token-11-1" pos="punct" morph="none" start_char="1020" end_char="1020">.</TOKEN>
</SEG>
<SEG id="segment-12" start_char="1023" end_char="1150">
<ORIGINAL_TEXT>The possible emergency use of baricitinib for hospitalized COVID-19 patients will be discussed with U.S. regulators, Lilly said.</ORIGINAL_TEXT>
<TOKEN id="token-12-0" pos="word" morph="none" start_char="1023" end_char="1025">The</TOKEN>
<TOKEN id="token-12-1" pos="word" morph="none" start_char="1027" end_char="1034">possible</TOKEN>
<TOKEN id="token-12-2" pos="word" morph="none" start_char="1036" end_char="1044">emergency</TOKEN>
<TOKEN id="token-12-3" pos="word" morph="none" start_char="1046" end_char="1048">use</TOKEN>
<TOKEN id="token-12-4" pos="word" morph="none" start_char="1050" end_char="1051">of</TOKEN>
<TOKEN id="token-12-5" pos="word" morph="none" start_char="1053" end_char="1063">baricitinib</TOKEN>
<TOKEN id="token-12-6" pos="word" morph="none" start_char="1065" end_char="1067">for</TOKEN>
<TOKEN id="token-12-7" pos="word" morph="none" start_char="1069" end_char="1080">hospitalized</TOKEN>
<TOKEN id="token-12-8" pos="unknown" morph="none" start_char="1082" end_char="1089">COVID-19</TOKEN>
<TOKEN id="token-12-9" pos="word" morph="none" start_char="1091" end_char="1098">patients</TOKEN>
<TOKEN id="token-12-10" pos="word" morph="none" start_char="1100" end_char="1103">will</TOKEN>
<TOKEN id="token-12-11" pos="word" morph="none" start_char="1105" end_char="1106">be</TOKEN>
<TOKEN id="token-12-12" pos="word" morph="none" start_char="1108" end_char="1116">discussed</TOKEN>
<TOKEN id="token-12-13" pos="word" morph="none" start_char="1118" end_char="1121">with</TOKEN>
<TOKEN id="token-12-14" pos="unknown" morph="none" start_char="1123" end_char="1125">U.S</TOKEN>
<TOKEN id="token-12-15" pos="punct" morph="none" start_char="1126" end_char="1126">.</TOKEN>
<TOKEN id="token-12-16" pos="word" morph="none" start_char="1128" end_char="1137">regulators</TOKEN>
<TOKEN id="token-12-17" pos="punct" morph="none" start_char="1138" end_char="1138">,</TOKEN>
<TOKEN id="token-12-18" pos="word" morph="none" start_char="1140" end_char="1144">Lilly</TOKEN>
<TOKEN id="token-12-19" pos="word" morph="none" start_char="1146" end_char="1149">said</TOKEN>
<TOKEN id="token-12-20" pos="punct" morph="none" start_char="1150" end_char="1150">.</TOKEN>
</SEG>
</TEXT>
</DOC>
</LCTL_TEXT>
